Hero background pattern

Developing the right pricing strategy for your product

We use a variety of pricing techniques and approaches to recommend the optimum value-based pricing for your product.

How can we support you:
Payer Insights
Pricing Strategy
BD Commercial Assessments
Tactical Pricing

We can help you

  • Obtain payer and stakeholder insights into the perceived value of your product
  • Identify the optimal price for your product
  • Determine the global pricing strategy
  • Understand payer evidence requirements to support your value-based pricing and reimbursement strategy
  • Conduct commercial assessments for business development assets
  • Implement pricing tactics to optimize post-launch pricing at a list and net price level
Get in touch

Discover the latest insights

Fimea launches pilot procedure for the evaluation …
Fimea program aims to standardise the initiation of assessment which are currently different for out…
Read more
windsor framework
The Project Orbis initiative
The Project Orbis initiative is an international partnership between medicines regulators in the UK,…
Read more
Italy AIFA reports on manufacturer paybacks
Collectively, companies still owe AIFA €370 million of the €2.8 billion that industry has to rep…
Read more
market access
PMA Insights: Week 7
We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi…
Read more
Spain’s Ministry of Health copies NICE, and …
Spain will ask pharmaceutical companies to submit their economic evaluation studies to reviewed late…
Read more
financial stabilisation act
Germany – European joint assessment at deadlock …
Germany’s BPI and vfa advise that the implementation of the European Health Technology Assessment (E…
Read more
What are the 5 Pricing & Market Access trends …
Our experts provide an overview of the five key trends that could shape the pricing and market acces…
Read more
market access
PMA Insights: Week 1
We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi…
Read more
EU HTA – looking back on 2022
Our market access experts cover the changes to the joint EU HTA process that occurred in 2022 and wh…
Read more
Are you ready for the new EU HTA in 2025?
Webinar: Our experts discuss the latest news and updates on the EU HTA process, including the Joint …
Read more

I really enjoyed working with Remap Consulting and received powerful advice. A small company like ours needs to receive a flexible approach in order start with market access activities, and I am very happy to see you are as flexible as possible with us.

Director of Market Access
Small pharma payer insights for clinical trials

Remap Consulting’s pricing knowledge and support has been critical to the success of our new pricing team. Their combined experience has provided them with ‘real-world‘ knowledge that can support their recommendations. I highly recommend Remap Consulting and am delighted to continue my work with their pricing group.

Senior Director, Head of Global Pricing
Outsourcing pricing activities for large biotech

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.